Frontlight ResearchEarly access
CompletedPhase 1
Bioequivalence study on aqueous humour concentrations of active ingredients after topical application of LEVIOSA® versus F2904. Randomized, parallel-group, blinded-assessor study in patients undergoing cataract surgery – BreAK Free
Key facts
- Who runs it
- Ntc S.r.l.
- Where
- Italy3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 90 people enrolled
- Started
- 22 Apr 2024
- Ended
- 20 Mar 2025
- Type of study
- Interventional
- Record updated
- 19 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Where is this trial?
It has sites in one country. Choose a country to see its sites.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 19 December 2024